4Garcia RL. Coltrera MD. Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed. embedded tissues. Comparison with flow cytometric analysis[J]. Am J Pathol.1989.134(4):733-739.
5张学军 刘维达 何春涤.现代皮肤病学基础[M].北京：人民卫生出版社,2001.1068.
6Chuh AA, Lee A, Molinari N. Case clustering in pityriasis rosea: a multicenter epidemiologic study in primary care settings in Hong Kong. Arch Dermatol, 2003, 139: 489-493.
7Traore A, Korsaga-Some N, Niamba P, et al. Pityriasis rosea in secondary schools in Ouagadougou, Burkina Faso. Ann Dermatol Venereol, 2001, 128: 605-609.
8Drago F, Malaguti F, Ranieri E, et al. Human herpes virus-like particles in pityriasis rosea lesions: an electron microscopy study. J Cutan Pathol, 2002, 29: 359-361.
9Watanabe T, Kawamura T, Jacob SE, et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol, 2002, 119: 793-797.
10Drago F, Ranieri E, Malaguti F, et al. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin.Dermatology, 1997,195: 374-378.
